Community Ophthalmology Practice Questions

Q: Which of the following is NOT a function of the District Blindness Control Society?

Training of ophthalmologists. The **District Blindness Control Society (DBCS)** is the decentralized implementation unit of the National Programme for Control of Blindness (NPCB) at the district level. Its primary role is the **management, coordination, and execution** of blindness control activities within its jurisdiction, rather than high-level technical training. ### Why Option A is Correct **Training of ophthalmologists** is a specialized, technical function carried out at the **State or National level** (through Regional Institutes of Ophthalmology, Medical Colleges, or designated Training Centers). The DBCS is responsible for identifying personnel who need training, but it does not possess the clinical infrastructure or academic mandate to conduct the training itself. ### Why the Other Options are Incorrect * **Financial and Material Management (B):** The DBCS is the nodal agency for the disbursement of funds to NGOs and government hospitals. It also manages the procurement and supply of consumables (like IOLs and sutures) for eye camps. * **Social Mobilization (C):** A core function of the DBCS is to involve the community, NGOs, and private practitioners to increase the "outreach" of eye care services. * **Creating Public Awareness (D):** The DBCS conducts Information, Education, and Communication (IEC) activities at the grassroots level to educate the public about cataract, refractive errors, and eye donation. ### High-Yield Clinical Pearls for NEET-PG * **NPCB Goal:** To reduce the prevalence of blindness to **0.25% by 2025**. * **Definition of Blindness (NPCB):** Visual acuity **<3/60** in the better eye with best possible correction. * **Funding:** Under the National Health Mission (NHM), DBCS receives grants-in-aid primarily for cataract surgeries (the "performance-linked" model). * **Composition:** The DBCS is usually chaired by the **District Collector/District Magistrate**, with the Chief Medical Officer (CMO) as the Vice-Chairman.

Q: According to the World Health Organization (WHO) definition, what visual acuity is considered blindness?

3/60. **Explanation:** The World Health Organization (WHO) defines **Blindness** based on the visual acuity in the **better eye with best possible correction**. According to the ICD-11 classification, blindness is defined as a visual acuity of **less than 3/60 (or a visual field of less than 10° around central fixation)**. **Why Option D is Correct:** * **3/60 (or 20/400):** This is the threshold for Category 3, 4, and 5 of visual impairment. If a person cannot see the top letter of a Snellen chart at 3 meters, they are classified as blind. **Why Other Options are Incorrect:** * **A (6/18):** This is the threshold for **Mild Visual Impairment**. Visual acuity equal to or better than 6/18 is considered "Normal" or "Mild" impairment. * **B (6/24):** This falls under the category of **Moderate Visual Impairment** (defined as <6/18 to 6/60). * **C (6/60):** This is the threshold for **Severe Visual Impairment** (defined as <6/60 to 3/60). While significant, it does not meet the technical WHO criteria for blindness. **High-Yield Clinical Pearls for NEET-PG:** 1. **NPCB (National Programme for Control of Blindness) India Definition:** Previously, India used <6/60 as the criteria for blindness to ensure more people received services. However, it has now been **aligned with the WHO definition (<3/60)** to maintain global uniformity. 2. **Visual Field:** Blindness is also defined as a visual field of less than 10° in the better eye, regardless of visual acuity (often seen in advanced Glaucoma or Retinitis Pigmentosa). 3. **Categories of Visual Impairment:** * **Low Vision:** <6/18 to 3/60. * **Blindness:** <3/60 to No Light Perception (NLP). 4. **Most Common Cause:** Globally and in India, **Cataract** remains the leading cause of blindness, followed by refractive errors.

Q: What prevalence of trachoma is considered an epidemic and an indication for mass chemoprophylaxis?

10%. The correct answer is **10%**. This threshold is a critical benchmark established by the World Health Organization (WHO) for the implementation of the **SAFE strategy** in controlling Trachoma. ### **Explanation of the Correct Answer** According to WHO guidelines for Community Ophthalmology, the prevalence of **Trachoma Inflammation—Follicular (TF)** in children aged 1–9 years determines the public health intervention required. When the prevalence of TF reaches **10% or higher** in a district/community, it is considered an epidemic level that necessitates **Mass Drug Administration (MDA)** or mass chemoprophylaxis. The standard treatment is a single oral dose of **Azithromycin** (20 mg/kg) or topical Tetracycline 1% eye ointment, administered annually to the entire community for at least three years. ### **Analysis of Incorrect Options** * **A (1%) & B (3%):** These levels are considered low prevalence. While surveillance is maintained, they do not trigger mass community-wide interventions. * **C (5%):** This is the threshold for **targeted intervention**. If the prevalence is ≥5% but <10%, antibiotic treatment is recommended at the household or targeted level rather than mass community distribution. ### **High-Yield Clinical Pearls for NEET-PG** * **SAFE Strategy:** **S**urgery (for Trichiasis), **A**ntibiotics (Azithromycin), **F**acial cleanliness, and **E**nvironmental improvement. * **WHO Grading (FISTO):** **F**ollicles (TF), **I**ntense Inflammation (TI), **S**carring (TS), **T**richiasis (TT), **O**pacity (CO). * **Drug of Choice:** A single dose of **Azithromycin** is preferred over Tetracycline due to better compliance. * **Elimination Goal:** WHO aims to eliminate trachoma as a public health problem, defined as a TF prevalence of **<5%** in children aged 1–9 years.

Q: According to the ninth revision of the International Classification of Diseases, what visual acuity in the better eye defines 'Visual impairment'?

6/60. ### Explanation The classification of visual impairment is a high-yield topic in Community Ophthalmology, primarily based on the **WHO/ICD-9** criteria. **1. Why 6/60 is the Correct Answer:** According to the ICD-9 (and the WHO classification), **Visual Impairment** is defined as a visual acuity of **less than 6/18 but equal to or better than 6/60** in the better eye with best possible correction. In the context of this question, 6/60 represents the threshold for "Low Vision" (Categories 1 and 2). Specifically: * **Low Vision:** < 6/18 to 3/60. * **Blindness:** < 3/60 to No Light Perception. **2. Analysis of Incorrect Options:** * **A. 6/18:** This is the upper limit of normal vision. Visual impairment is defined as vision *worse* than 6/18. * **B. 6/36:** While 6/36 falls within the range of visual impairment (Category 1), it is not the defining threshold or the standard cutoff used in the classification. * **D. 3/60:** This is the critical cutoff for **Blindness** (Category 3). Vision less than 3/60 in the better eye is defined as economic blindness/WHO blindness. **3. NEET-PG High-Yield Pearls:** * **NPCB (India) Definition:** National Programme for Control of Blindness recently updated its criteria to align with WHO. Blindness is now defined as VA **< 3/60** (previously it was < 6/60). * **Categories of Visual Impairment (WHO):** * **Category 1:** < 6/18 to 6/60 (Moderate impairment) * **Category 2:** < 6/60 to 3/60 (Severe impairment) * **Category 3, 4, 5:** Blindness (ranging from < 3/60 to NLP) * **Economic Blindness:** VA < 6/60 (The level at which an individual cannot perform their profession).

Q: Which of the following is the earliest clinical sign of Vitamin A deficiency?

Conjunctival xerosis. **Explanation:** Vitamin A deficiency (VAD) follows a specific clinical progression as classified by the WHO. Understanding the distinction between the earliest **symptom** and the earliest **sign** is critical for NEET-PG. **1. Why Conjunctival Xerosis is correct:** Conjunctival xerosis (WHO Grade X1A) is the **earliest clinical sign** of Vitamin A deficiency. It is characterized by a lack of luster, dryness, and a "muddy" appearance of the bulbar conjunctiva due to the loss of goblet cells and keratinization of the epithelium. While night blindness is the earliest *symptom*, conjunctival xerosis is the first objective change a clinician can observe during an examination. **2. Analysis of Incorrect Options:** * **Bitot’s Spot (X1B):** These are triangular, foamy, silvery-white patches on the bulbar conjunctiva. While highly characteristic of VAD, they appear *after* initial xerosis. * **Corneal Xerosis (X2):** This represents a more advanced stage where the cornea becomes hazy and dry. It occurs after conjunctival changes. * **Keratomalacia (X3A/X3B):** This is the most severe stage, involving liquefactive necrosis and perforation of the cornea. It is a late manifestation leading to irreversible blindness. **3. Clinical Pearls for NEET-PG:** * **Earliest Symptom:** Night Blindness (Nyctalopia/XN). * **Earliest Sign:** Conjunctival Xerosis (X1A). * **Most Characteristic Sign:** Bitot’s spots (X1B). * **WHO Classification (XN to X3):** XN (Night blindness) → X1A (Conjunctival xerosis) → X1B (Bitot’s spots) → X2 (Corneal xerosis) → X3A/B (Keratomalacia). * **Treatment:** For children >1 year, the standard dose is 200,000 IU of Vitamin A orally on days 0, 1, and 14.

Q: The GET strategy is used for the management of which disease?

Trachoma. **Explanation:** The **GET 2020** (Global Elimination of Trachoma by 2020) strategy was launched by the WHO to eliminate blinding trachoma as a public health problem. The core of this strategy is the **SAFE** acronym, which is a high-yield concept for NEET-PG: * **S:** Surgery (for Trichiasis) * **A:** Antibiotics (Azithromycin 20mg/kg single dose) * **F:** Facial cleanliness * **E:** Environmental improvement (water and sanitation) **Analysis of Options:** * **Trachoma (Correct):** Caused by *Chlamydia trachomatis* (Serotypes A, B, Ba, C). It is the leading infectious cause of blindness worldwide. The GET strategy focuses on community-wide interventions to break the transmission cycle. * **Onchocerciasis:** Managed primarily through the **APOC** (African Programme for Onchocerciasis Control) using annual mass drug administration of **Ivermectin** (Mectizan). * **Cataract:** Addressed under **Vision 2020: The Right to Sight**. The focus is on increasing the Cataract Surgical Rate (CSR) and utilizing IOL implantations. * **Vitamin A Supplementation:** Part of the **National Prophylaxis Programme against Nutritional Blindness**, involving periodic high-dose Vitamin A (2 lakh IU) for children aged 6–60 months. **High-Yield Clinical Pearls:** * **WHO Grading (FISTO):** Follicular, Intense, Scarring, Trichiasis, Opacity. * **Drug of Choice:** Oral **Azithromycin** is preferred over Tetracycline eye ointment for mass treatment due to better compliance. * **Vector:** The common housefly (*Musca sorbens*) acts as a mechanical vector. * **India Status:** India was declared free from infective trachoma in 2017, but surveillance for chronic stages (Trichiasis) continues.

Question 1

Revised strategies of the National Programme for Control of Blindness include all except?

Accepted Answer

To shift from fixed facility surgical approach to eye camp approach

Answer

To strengthen participation of voluntary organizations

Answer

To enhance coverage of eye care services in tribal and other under-served areas

Answer

To strengthen services for transplantation of cornea and treatment of glaucoma

Question 2

Which of the following is NOT a function of the District Blindness Control Society?

Accepted Answer

Training of ophthalmologists

Answer

Financial and material management

Answer

Social mobilization

Answer

Creating public awareness

Question 3

According to the World Health Organization (WHO) definition, what visual acuity is considered blindness?

Accepted Answer

3/60

Answer

6/18

Answer

6/24

Answer

6/60

Question 4

Which one of the following is not a target disease under Vision 2020: The Right to Sight?

Accepted Answer

Trachoma

Answer

Refractive error

Answer

Corneal blindness

Answer

Diabetic retinopathy

Question 5

What prevalence of trachoma is considered an epidemic and an indication for mass chemoprophylaxis?

Accepted Answer

10%

Answer

1%

Answer

3%

Answer

5%

Question 6

According to the ninth revision of the International Classification of Diseases, what visual acuity in the better eye defines 'Visual impairment'?

Accepted Answer

6/60

Answer

6/18

Answer

6/36

Answer

3/60

Question 7

Which of the following is the earliest clinical sign of Vitamin A deficiency?

Accepted Answer

Conjunctival xerosis

Answer

Bitot's spot

Answer

Corneal xerosis

Answer

Keratomalacia

Question 8

According to the National Programme for the Control of Blindness (NPCB) Vision 2020, how many centers of excellence are planned?

Accepted Answer

20

Answer

20000

Answer

2000

Answer

200

Question 9

Which of the following methods is used to determine the prevalence of glaucoma and ARMD?

Accepted Answer

High-risk screening

Answer

Mass screening

Answer

Sentinel survey

Answer

Rapid assessment of avoidable blindness (RAAB) survey

Question 10

The GET strategy is used for the management of which disease?

Accepted Answer

Trachoma

Answer

Onchocerciasis

Answer

Cataract

Answer

Vitamin A supplementation

Community Ophthalmology — MCQs

Community Ophthalmology — MCQs

On this page

Practice by Chapter

Want unlimited practice?